First human trial: spinal fluid vaccine targets deadly breast cancer brain spread
NCT ID NCT05809752
Summary
This early-stage study is testing a personalized immune vaccine for breast cancer patients whose cancer has spread to the membranes surrounding the brain and spinal cord. Researchers will inject the vaccine directly into the spinal fluid to see if it's safe and to find the highest dose patients can tolerate. The goal is to see if this approach can help control this difficult-to-treat complication of breast cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Memorial Sloan Kettering Cancer Center
WITHDRAWNNew York, New York, 10065, United States
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Contact
Contact
-
Roswell Park Comprehensive Cancer Center
WITHDRAWNBuffalo, New York, 14263, United States
Conditions
Explore the condition pages connected to this study.